Role of Endothelial Growth Factor in Bronchial Asthma Control in Children

Bibliography link: Potapova N.L., Gaymolenko I.N., Tereshkov P.P. Role of Endothelial Growth Factor in Bronchial Asthma Control in Children. Doctor.Ru. 2020; 19(3): 40–43. (in Russian) DOI: 10.31550/1727-2378-2020-19-3-40-43
19 May 10:59

Study Objective: to study vascular endothelial growth factor (VEGF-A) levels in children with controlled and uncontrolled bronchial asthma (CBA and UBA).

Study Design: cross-sectional study.

Materials and Methods. 71 children with BA were examined (37 children with moderate and 34 children with severe BA); examination included history analysis, clinical examination, measurement of eosinophils in peripheral blood, total plasma IgE, spirometry. The mean age of patients was 9.0 ± 2.5 years old. VEGF-A concentration was measured in two independent samplings: with satisfactory BA control (n = 26) and UBA (n = 25).

Study Results. In moderate BA, VEGF-A concentration was 1.4-times higher in uncontrolled BA than in patients with satisfactory control. 1.8-times increase inVEGF-A concentration (р< 0.05) was noted in severe UBA as compared to CBA; it assumes VEGF-A synthesis initiation in children with long-term chronic respiratory inflammation and demonstrates its involvement in remodelling processes which are most prominent in uncontrolled BA. Interrelation analysis of VEGF-А and pulmonary ventilation indicators revealed significant moderate negative relation with forced expiratory volume during first second (rs = –0.34) and forced vital respiratory capacity (rs = –0.51) in severe UBA (р< 0.05).

Conclusion. Our results correlate with results of other studies where VEGF-A was treated as angiogenesis marker in bronchial remodelling. It allows assuming that it is a potential therapeutic target in development of antiangiogenics to control BA.

Contribution: Potapova, N.L. — patient selection, examination and management, thematic publications reviewing; Gaymolenko, I.N. — study design, review of critically important material, approval of the manuscript for publication; Tereshkov, P.P. — lab tests, data analysis and interpretation.

Conflict of interest: The authors declare that they do not have any conflict of interests.

N.L. Potapova (Corresponding author) — Chita State Medical Academy of the Ministry of Health of the Russian Federation; 39A Gorky Str., Chita, Russian Federation 672000. eLIBRARY.RU SPIN: 7460-4199. ORCID: E-mail:

I.N. Gaymolenko — Chita State Medical Academy of the Ministry of Health of the Russian Federation; 39A Gorky Str., Chita, Russian Federation 672000. eLIBRARY.RU SPIN: 7875-0742. ORCID: E-mail:

P.P. Tereshkov — Chita State Medical Academy of the Ministry of Health of the Russian Federation; 39A Gorky Str., Chita, Russian Federation 672000. eLIBRARY.RU SPIN: 5228-8808. ORCID: E-mail:


Clinical profile of patients with controlled and uncontrolled bronchial asthma (CBA and UBA)


* Difference from severe controlled bronchial asthma group under Mann-Whitney test is statistically significant (р < 0.05).

Received: 26.12.2019
Accepted: 20.01.2020

19 May 10:59
  1. Ovsyannikov N.V., Bileviсh O.A, Zinchenko L.M, Kozlova E.A. New opportunities in achievement control over the course of severe bronchial asthma. Bull. of Contemporary Clinical Medicine. 2019; 12(4): 63–8. (in Russian). DOI: 10.20969/VSKM.2019.12(4).63-68
  2. Pavord I.D., Afzalnia S., Menzies-Gow A., Heaney L.G. The current and future role of biomarkers in type 2 cytokine-mediated asthma management. Clin. Exp. Allergy. 2017; 47(2): 148–60. DOI: 10.1111/cea.12881
  3. Titova O.N., Kuzubova N.A., Lebedeva E.S. Endothelial dysfunction and obstructive lung pathology. Russian Journal of Physiology. 2016; 102(12): 1420–32. (in Russian)
  4. Lebedebko A.A., Semernik O.E., Avanesyan A.A. The role of vascular endothelial growth factor in genesis of allergic inflammation in children with asthma. Journal of Fundamental Medicine and Biology. 2014; 3: 24–8. (in Russian)
  5. Fehrenbach H., Wagner C., Wegmann M. Airway remodeling in asthma: what really matters. Cell Tissue Res. 2017; 367(3): 551–69. DOI:10.1007/s00441-016-2566-8
  6. Lee H.Y., Min K.H., Lee S.M., Lee J.E., Rhee C.K. Clinical significance of serum vascular endothelial growth factor in young male asthma patients. Korean J. Intern. Med. 2017; 32(2): 295–301. DOI: 10.3904/kjim.2014.242
  7. Zou H., Fang Q.H., Ma Y.M., Wang X.Y. Analysis of growth factors in serum and induced sputum from patients with asthma. Exp. Ther. Med. 2014; 8(2): 573–8. DOI: 10.3892/etm.2014.1759
  8. Green C.E., Turner A.M. The role of the endothelium in asthma and chronic obstructive pulmonary disease (COPD). Respir. Res. 2017; 18(1): 20. DOI: 10.1186/s12931-017-0505-1
  9. Kim J.H. Serum vascular endothelial growth factor as a marker of asthma exacerbation. Korean J. Intern. Med. 2017; 32(2): 258–60. DOI: 10.3904/kjim.2017.066
  10. State Program “Bronchial asthma in children. Management and prevention strategy.” M.: Original Market; 2017. 160 p. (in Russian)
  11. Global Strategy for Asthma Management and Prevention. Revised 2019. URL: (access date: 15.02.2020).
  12. Lo D., Maniyar A., Gupta S., Gaillard E. High prevalence of bronchiectasis on chest CT in a selected cohort of children with severe Asthma. BMC Pulm. Med. 2019; 19(1): 136. DOI: 10.1186/s12890-019-0900-0
  13. Fassakhov R.S. Significant role of small respiratory tracts: new possibilities of cyclesonide in therapy of bronchial asthma. Medical Council. 2017; 18: 56–60. (in Russian). DOI: 10.21518/2079-701X-2017-18-56-60
Новости мировой медицины! Свежие статьи из журнала! Будьте в курсе!

Похожие статьи

Similar article
19 April 00:00, Interview
Doctor.Ru Pediatrics. Vol. 20, No. 3 (2021)
19 April 00:00, Paediatrics
A.V. Aksenov, E.A. Ivanovskaya
Successful Use of Tocilizumab in a Child with Systemic Juvenile Idiopathic Arthritis
Doctor.Ru Pediatrics. Vol. 20, No. 3 (2021)